Pollen Projects is a non-alcoholic venture studio based in Essex, where Jack heads up the research and development of new projects. Their first project; seasn, aims to bring uniquely flavoured LIGHT and DARK cocktail bitters to the industry without alcohol.
The second project; Sylva is a love letter to the core of what makes dark spirits so alluring, namely the exploration of grain and wood, whilst utilising super modern culinary techniques to extract unique flavours unseen in traditional spirits.
Jack has been a part of the drinks industry for the past decade, working in many parts of the sector from world-leading high-end wine cocktail service, spirits brand advocacy, RTD development and project consultancy. He was part of the Dandelyan team to win both World’s Best Bar from Tales of the Cocktail and No.1 at 50 Bets Bars, he created Auchentoshan’s Bartender’s Malt edition one and was the liquid development lead for Whitebox Cocktails series of canned cocktails.
With 17yrs’ experience in FMCG, 10 of these in the non-alcoholic Beverages Category, Lucy has strong expertise on what it takes to develop winning beverages, aligned to consumer needs. Her current role sees her focusing on developing portfolios that are not just tasty and refreshing – but also permissible. She has consistently strengthened Lipton’s category-leading position on sustainability, making products that are more sustainable by design for both People & Planet across their entire lifecycle.
Cesare is co-founder and Chief Operating Officer of Oncoheroes Biosciences Inc., a Boston-based biotech company focused on pediatric oncology drug development. Cesare has more than 20 years of experience in the drug development field, in both scientific and commercial roles. Previously, he held senior positions at AMRI, Aptuit Laurus, ThalesNano and Auxiliis. Cesare started his career as research scientist in a pharmaceutical company (Eisai, London) and in academia (Institute of Enzymology, Budapest).
Following the death of his first daughter Laura to cancer, Cesare set up aPODD Foundation, a London-based charity focused on accelerating paediatric oncology drug development. As aPODD’s chairman he is actively involved on a pro-bono basis in drug repurposing projects, advocacy efforts and research collaborations.
Cesare holds an MSc in Applied Molecular Biology and a PhD in Neurosciences from UCL, University of London, as well as an MBA from the Central European University, Budapest.
– MS (PhD course completion), RN, APN of Oncology
– Experience in clinical trials for 22 years;
- developed whole clinical regulatory package for new anti-cancer immunotherapy in ImmunoneOncia Therapeutics Inc. (current)
- developed whole clinical regulatory package and gained the approval for biosimilars from EMA, FDA and PMDA in CELLTRION Inc.
- developed the systemized data capturing module and clinical study conducting program in National Cancer Center Korea
– Published 30 articles and 53 congress presentations (including The Lancet, Lancet Oncology, Lancet Hematology, etc)
